The life sciences industry has long been at the forefront of innovation, and 2025 promises to continue this trajectory with exciting developments in intellectual property (IP), licensing, and mergers and acquisitions (M&A)....more
1/20/2025
/ Acquisitions ,
Artificial Intelligence ,
Biologics ,
Biosimilars ,
Data Protection ,
Innovation ,
Intellectual Property Protection ,
IP License ,
Life Sciences ,
Machine Learning ,
Mergers ,
Patents ,
Pharmaceutical Industry ,
Popular
At a time marked by themes of “push” and “pull,” organizations across all sectors and jurisdictions are grappling with the pursuit of innovation within an increasingly complex regulatory framework. Over the next 12 months,...more
Private equity firms, financial sponsors, and sovereign wealth funds continue to invest in global sports organizations. Financial sponsor–led investments were more prevalent at the beginning of the century in Europe and...more
4/28/2023
/ Institutional Investors ,
Investors ,
MLB ,
NBA ,
NFL ,
NHL ,
Private Equity ,
Private Equity Firms ,
Spectator Sports ,
Sports ,
WNBA